P

Pfizer

Makes cancer drugs, vaccines and other medicines

QC Senior Scientist - Analytical

Full-TimePosted on 10/27/2026Deadline 11/4/26
$99.2k - $165.4k/yr
Mid, Senior
Bachelor's, Master's, PhD, Associate's
Sanford, NC, USA
In PersonOn-premise in Sanford, North Carolina.
Biology & BiotechRegulatory & Quality (Life Sciences)
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree with at least 4 years of experience, a master's degree with at least 2 years of experience, a PhD with 0 or more years of experience, an associate's degree with 8 years of experience, or a high school diploma or equivalent with 10 years of relevant experience.
  • Manufacturing, quality, or laboratory experience in the biotechnology or pharmaceutical industry.
  • Technical subject-matter expertise in laboratory practices, analytical testing, and analytical equipment, including UV-visible spectroscopy, high-performance liquid chromatography, ultra-performance liquid chromatography, pH, appearance, osmolality, total organic carbon, and conductivity.
  • Knowledge of United States, European Union, and rest-of-world current Good Manufacturing Practices; pharmacopeias; International Council for Harmonisation guidelines; analytical techniques and instrumentation; Laboratory Information Management Systems; TrackWise Global Quality Tracking System; Microsoft Word, Excel, and PowerPoint; statistical software such as JMP and Minitab; Lean Six Sigma concepts; Lean Labs; project management tools including stakeholder management; formal quality change control, investigations, and documentation systems; and Quality Risk Management, including risk assessments.
  • Ability to lift 30 pounds, stand or sit for 2 to 3 hours at a time, walk long distances, and bend to obtain items from lower shelving or cabinets.
  • Intellectual capacity to perform mathematical problems and data analysis.
  • Must be authorized to be employed in the United States by any employer and have permanent work authorization in the United States.
Responsibilities
  • Perform tasks to maintain and improve current Good Manufacturing Practice-compliant Quality Control and/or Stability laboratories.
  • Perform testing of clinical and/or commercial products, raw materials, validation samples, and stability samples as needed.
  • Train junior colleagues and develop training plans and/or oversee training activities for groups.
  • Assess existing situations and suggest continuous improvements to increase compliance and innovation.
  • Analyze and interpret Quality Control results; make decisions regarding accuracy, completeness, and compliance; perform data trending; evaluate trending reports; and influence or agree actions with key stakeholders.
  • Design, review, approve, and provide final authorization for Good Manufacturing Practice documentation, including test results and records, validation protocols and reports, method transfer protocols and reports, test methods, equipment records, process technology transfer activities, and regulatory filing documents; ensure adherence to regulatory agency requirements, International Council for Harmonisation guidelines, Pfizer standards, policies, and values.
  • Detail requirements for Laboratory Information Management System builds and/or build and test new builds and master data changes.
  • Significantly contribute to and/or lead laboratory investigations into events and out-of-specification results; evaluate and approve corrective and preventive actions addressing root causes to prevent recurrence.
  • Report issues to management and lead issue resolution or independently resolve issues, including reporting out-of-specification results, participating in or leading associated laboratory investigations, reporting instrument issues, and assisting with, conducting, or leading troubleshooting activities.
  • Initiate and lead working groups and/or manage projects or changes to accomplish change activities, project deliverables, and complete projects; prioritize activities and deliverables and ensure timely completion and adherence to project timelines.
  • Improve and automate existing methodologies and develop new methodologies and technologies.
  • Serve on cross-functional teams representing Quality Operations and facilitate communications and activities or projects between Quality Operations and site departments and/or the network; serve as a technical subject-matter expert and make decisions on behalf of Quality Operations.
  • May manage a business system, such as a Laboratory Information Management System or stability system, or a product from the Quality Organization perspective.
  • Perform Good Manufacturing Practice tasks and activities associated with compliant Quality Control and Stability laboratories; analyze, interpret, and trend results and data; create, review, execute, and approve documentation; participate in and/or lead investigations of events and out-of-specification results; and design, organize, and/or conduct assay development, automation, troubleshooting, method transfer, and validation activities.
  • Drive continuous improvement, Operational Excellence, and innovative implementations; represent Quality Control and make decisions on cross-functional teams; lead projects and/or teams by providing guidance, training, and coaching to junior colleagues; and conduct project management for site and network projects.
  • Support audits and review and approve technical content for scientific merit and compliance with regulatory agency requirements, Pfizer policies, and standards.
  • Identify issues, present complex problems with possible solutions, and take a leadership role in resolving or independently resolve complex issues.
  • Develop action plans using discipline principles, appropriate procedures, and leadership skills, and contribute to execution toward individual, team, and project goals.
  • Solve complex mathematical problems and multifaceted, situation-dependent problems using ambiguous information.
  • Apply Method 1 tools to solve complex issues, implement approaches to problem solving, and coach others toward Method 1 certification as applicable.
  • Collaborate with co-workers, customers, and management across the network to gather input and background knowledge needed to complete assignments.
  • Make accurate decisions and documentation using knowledge of Pfizer procedures, policies, standards, quality systems, technical experience, and industry guidance and regulations.
  • Consider future quality and compliance impacts and impacts on the work group, department, and site when making decisions.
  • Represent Quality Control on site and network teams, forums, and summits supporting site or network operations; influence and negotiate with business lines and share information with Quality Operations.
  • Act as a change agent who fosters continuous improvement behaviors in others.
  • Identify when personal, project, team, department, or network goals or deliverables are off schedule, take remedial action, and/or seek advice.
  • Deliver large, complex, high-business-impact projects, activities, and changes.
  • Review and authorize laboratory data and maintain extensive overall knowledge of laboratory operations.
  • Design and create, organize execution of, review, and approve compliant test method transfer and validation protocols and reports, equipment qualification and computer validation records, and assist with protocol non-conformance evaluations.
  • Identify and seek external resources, such as PDA and ISPE, to build or enhance scientific knowledge; support staff training; coach junior colleagues; and seek a mentor.
  • Independently design projects or studies and make significant contributions to methodology development, improvement, and troubleshooting, including new technologies and automation.
  • Independently handle complex investigations in the investigations quality system and determine associated corrective and preventive actions.
Desired Qualifications
  • Proficiency in analytical techniques, particularly liquid chromatography-mass spectrometry.
  • Understanding of separation technologies such as liquid chromatography.
  • Experience mentoring and guiding team members.
  • Experience using common artificial intelligence tools, including generative technologies such as ChatGPT or Microsoft Copilot, to support problem solving and enhance work.

About the company

Pfizer discovers, makes, and sells prescription medicines and vaccines for patients, doctors, and governments worldwide, with large businesses in vaccines, cancer, heart disease, and rare diseases. In 2020, its COVID-19 shot, developed with German partner BioNTech, became the first COVID-19 vaccine authorized in the United States. Its scientists find drug candidates and run clinical trials to prove they are safe and effective, and Pfizer then manufactures approved products in its own plants, earning most of its money from patented drugs before cheaper generic copies arrive. Pfizer was founded in 1849 as a chemicals business in Brooklyn and is based in New York City.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Get referred to Pfizer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Newer drugs carry the business: launched and acquired products grew 18% operationally in Pfizer's August 2026 quarterly report.
  • The outlook improved: in August 2026, Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion.
  • Vaccine scientists get room to grow: Pfizer's $470 million Pearl River, New York research expansion is designed for 370 workers.

What critics are saying

  • Expect more site cuts: in November 2025, Pfizer moved to shrink Swiss staff from about 300 to roughly 70.
  • Generics will erase sales: Pfizer expects patent losses to cut $17 billion to $18 billion of yearly revenue through 2028.
  • Pfizer is chasing obesity leaders: Metsera's monthly shot showed 12.3% weight loss at 28 weeks in February 2026 data.

What makes Pfizer unique

  • Pfizer bought its way into cancer: its Seagen buyout added antibody-drug conjugates, which carry chemotherapy straight to tumors.
  • Pfizer is betting on monthly obesity shots: Metsera's berobenatide is dosed once a month, unlike weekly Wegovy and Zepbound.
  • Pfizer leans on one partnered heart drug: blood thinner Eliquis, sold with Bristol Myers Squibb, brings about 14% of revenue.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Hybrid Work Options
  • Relocation Assistance

Growth & Insights and Company News

6 month growth

-3%

1 year growth

-2%

2 year growth

-2%
Yahoo Finance
Oct 22nd, 2026
Pfizer's 5.7% yield signals risk: dividends took 108% of free cash flow vs Merck's 66%

Merck's dividend looks safer than Pfizer's, despite Pfizer's higher yield, according to a 24/7 Wall St. comparison. Pfizer yields about 5.7% against Merck's 2.2%. In 2025, Pfizer's dividends used 108% of free cash flow, while Merck's used 66%. In the first half of 2026, Merck's free cash flow covered 174% of its payout; Pfizer's covered about 51%. Merck has raised its quarterly dividend 39% since 2020, to $0.85. Pfizer's rose 13% and has been flat at $0.43 since January 2025. Pfizer is cheaper, at about 10 times 2026 earnings against Merck's 17. Pfizer targets a return to growth from 2029, while Merck's newer drugs are already selling.

Yahoo Finance
Oct 21st, 2026
Pfizer announces layoffs at Rocky Mount and Sanford sites, but gives no numbers

Pfizer has announced layoffs at its Rocky Mount and Sanford facilities in North Carolina, as part of a push to improve efficiency. It told employees of the cuts on Tuesday but did not say how many jobs will go, when, or in which departments. Rocky Mount makes sterile injectables, while Sanford focuses on vaccines and advanced biologics, including gene therapies. "Headcount reductions are a part of this initiative," Pfizer said, adding that it will give affected staff support services. "If indeed this happens, it's going to affect those families," said David Farris, president and chief executive officer of the Rocky Mount Area Chamber of Commerce. The impact on local economies, he said, depends on the number laid off. As of Wednesday afternoon, no Worker Adjustment and Retraining Notification (WARN) notice had been filed with the state.

Yahoo Finance
Oct 19th, 2026
Five low-beta dividend stocks: Pfizer yields 5.83%, Coca-Cola raises payout since 1999

Five defensive dividend stocks offer income with less volatility than the broader market, according to a 24/7 Wall St. analysis. All five have a beta well below 1, meaning they have historically moved less than the market. Pfizer leads with a forward yield of 5.83% at $29.49 a share. AT&T yields 4.77% at $23.27, and its $1.11 dividend uses about 42% of 2026 free cash flow guidance of $18B+. Debt of $144B is its main risk. Dominion Energy yields 4.24%, while Coca-Cola and Colgate-Palmolive each yield 2.27%. Coca-Cola has raised its dividend every year since 1999, and Colgate's next ex-dividend date is October 20, 2026.

Yahoo Finance
Oct 15th, 2026
GSK beats Pfizer as dividend stock: 39% payout vs 89% of free cash flow

GSK looks the better dividend stock than Pfizer, according to a comparison of the two drugmakers, which both face major patent losses before 2030. Pfizer yields 6.3% and GSK 4.1%. Over the twelve months to June 2026, Pfizer paid out 89% of its free cash flow in dividends ($9.79 billion of $10.98 billion), against 39% at GSK (£2.67 billion of £6.90 billion). Pfizer's chief executive officer, Albert Bourla, said the dividend will be maintained even in "the most stretched scenarios." Pfizer raised its 2026 revenue guidance to $60.5 billion to $62.5 billion. GSK raised its dividend 17.6% in fiscal 2025 after an earlier cut, and Q2 2026 sales rose 5%. Its main risk is debt: net debt rose to £22 billion after the Nuvalent acquisition.

Yahoo Finance
Oct 14th, 2026
Pfizer's 6% dividend pays investors to wait as oncology pipeline drives growth beyond COVID-19

Pfizer offers a dividend yield of just over 6% while it builds growth beyond its COVID-19 products. The drugmaker declared a quarterly dividend of $0.43 in June 2026, its 351st consecutive quarterly payment. In the second quarter, revenue from launched and acquired products rose 18% year over year. Pfizer raised the midpoint of its full-year guidance, helped by stronger non-COVID sales from drugs such as Eliquis, Padcev, and Vyndaqel. Oncology is the next focus. Pfizer is investing in antibody-drug conjugates and bispecific antibodies, and it entered a global collaboration with Innovent Biologics covering 12 early-stage cancer programs. Not every experimental drug will succeed, but a broader pipeline improves the odds. If new medicines work, the share price could rise on top of the dividend income.